Clinical Trials Browser

Not yet recruiting × Lymphoma, T-Cell, Peripheral × 30 days × Clear all

NCT07615283 2026-05-29

Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma

Phase 1/2 Not yet recruiting

Recurrence, Lymphoma, T-Cell, Peripheral